The same group also found that COL11A1 could be used as a specific marker for activated CAFs, and COL11A1 expression was correlated with tumor stage, tumor grade and patients’ outcome in 13 types of carcinomas (Jia et al., 2016). The gene discussed is COL11A1; the disease is carcinoma.